| Income Statement |
| Operating Expenses | 7.62M |
|
| Research and Development Expense | 3.91M |
| Selling, General and Administrative Expense | 3.71M |
| Operating Income | -7.62M |
| Net Income | -5.75M |
| Net Income Common Stock | -5.75M |
| Net Income Common Stock (USD) | -5.75M |
| Consolidated Income | -5.75M |
| Earnings per Basic Share | -0.18 |
| Earnings per Basic Share (USD) | -0.18 |
| Earnings per Diluted Share | -0.18 |
| Earning Before Interest & Taxes (EBIT) | -5.75M |
| Earning Before Interest & Taxes (USD) | -5.75M |
| Weighted Average Shares | 31.91M |
| Weighted Average Shares Diluted | 31.91M |
| Balance Sheet |
| Cash and Equivalents | 237.47M |
| Cash and Equivalents (USD) | 237.47M |
| Current Assets | 238.49M |
| Total Assets | 240.63M |
| Current Liabilities | 2.05M |
| Total Liabilities | 2.05M |
| Accumulated Retained Earnings (Deficit) | -195.86M |
| Shareholders Equity | 238.58M |
| Shareholders Equity (USD) | 238.58M |
| Assets Non-Current | 2.13M |
| Goodwill and Intangible Assets | 127.19K |
| Trade and Non-Trade Payables | 2.05M |
| Cash Flow |
| Net Cash Flow from Financing | 25.32M |
| Net Cash Flow / Change in Cash & Cash Equivalents | 21.79M |
| Issuance (Purchase) of Equity Shares | 25.82M |
| Net Cash Flow from Investing | -180.00 |
| Net Cash Flow from Operations | -3.53M |
| Share Based Compensation | 1.44M |